Global Diabetes Lancing Devices Market Research Report 2023

Publication ID:

PB511236433

Publication Date:

November 3, 2023

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Medical Devices [2]

Pharma & Healthcare [3]

Description:

Diabetes Lancing Devices, also known as lancets, are medical devices used by people with diabetes to obtain a small blood sample for blood glucose testing. These devices typically consist of a sharp, spring-loaded needle that is used to prick the fingertip, allowing the user to measure their blood sugar levels using a glucose meter.
The global Diabetes Lancing Devices market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Diabetes Lancing Devices market with multiple angles, which provides sufficient supports to readers鈥� strategy and decision making.
By Company
Roche
LifeScan
Abbott
Ascensia
B. Braun
Terumo
ARKRAY
Trividia Health
SANNUO
GMMC
BIONIME
Segment by Type
Adjustable Lancing Device
Non-adjustable Lancing Device
Segment by Application
Household
Commercial
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Diabetes Lancing Devices report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers鈥� Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers鈥� Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Diabetes Lancing Devices Market Overview
1.1 Product Overview and Scope of Diabetes Lancing Devices
1.2 Diabetes Lancing Devices Segment by Type
1.2.1 Global Diabetes Lancing Devices Market Value Comparison by Type (2023-2029)
1.2.2 Adjustable Lancing Device
1.2.3 Non-adjustable Lancing Device
1.3 Diabetes Lancing Devices Segment by Application
1.3.1 Global Diabetes Lancing Devices Market Value by Application: (2023-2029)
1.3.2 Household
1.3.3 Commercial
1.4 Global Diabetes Lancing Devices Market Size Estimates and Forecasts
1.4.1 Global Diabetes Lancing Devices Revenue 2018-2029
1.4.2 Global Diabetes Lancing Devices Sales 2018-2029
1.4.3 Global Diabetes Lancing Devices Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Diabetes Lancing Devices Market Competition by Manufacturers
2.1 Global Diabetes Lancing Devices Sales Market Share by Manufacturers (2018-2023)
2.2 Global Diabetes Lancing Devices Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Diabetes Lancing Devices Average Price by Manufacturers (2018-2023)
2.4 Global Diabetes Lancing Devices Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Diabetes Lancing Devices, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Diabetes Lancing Devices, Product Type & Application
2.7 Diabetes Lancing Devices Market Competitive Situation and Trends
2.7.1 Diabetes Lancing Devices Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Diabetes Lancing Devices Players Market Share by Revenue
2.7.3 Global Diabetes Lancing Devices Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Diabetes Lancing Devices Retrospective Market Scenario by Region
3.1 Global Diabetes Lancing Devices Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Diabetes Lancing Devices Global Diabetes Lancing Devices Sales by Region: 2018-2029
3.2.1 Global Diabetes Lancing Devices Sales by Region: 2018-2023
3.2.2 Global Diabetes Lancing Devices Sales by Region: 2024-2029
3.3 Global Diabetes Lancing Devices Global Diabetes Lancing Devices Revenue by Region: 2018-2029
3.3.1 Global Diabetes Lancing Devices Revenue by Region: 2018-2023
3.3.2 Global Diabetes Lancing Devices Revenue by Region: 2024-2029
3.4 North America Diabetes Lancing Devices Market Facts & Figures by Country
3.4.1 North America Diabetes Lancing Devices Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Diabetes Lancing Devices Sales by Country (2018-2029)
3.4.3 North America Diabetes Lancing Devices Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Diabetes Lancing Devices Market Facts & Figures by Country
3.5.1 Europe Diabetes Lancing Devices Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Diabetes Lancing Devices Sales by Country (2018-2029)
3.5.3 Europe Diabetes Lancing Devices Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Diabetes Lancing Devices Market Facts & Figures by Country
3.6.1 Asia Pacific Diabetes Lancing Devices Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Diabetes Lancing Devices Sales by Country (2018-2029)
3.6.3 Asia Pacific Diabetes Lancing Devices Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Diabetes Lancing Devices Market Facts & Figures by Country
3.7.1 Latin America Diabetes Lancing Devices Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Diabetes Lancing Devices Sales by Country (2018-2029)
3.7.3 Latin America Diabetes Lancing Devices Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Diabetes Lancing Devices Market Facts & Figures by Country
3.8.1 Middle East and Africa Diabetes Lancing Devices Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Diabetes Lancing Devices Sales by Country (2018-2029)
3.8.3 Middle East and Africa Diabetes Lancing Devices Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Diabetes Lancing Devices Sales by Type (2018-2029)
4.1.1 Global Diabetes Lancing Devices Sales by Type (2018-2023)
4.1.2 Global Diabetes Lancing Devices Sales by Type (2024-2029)
4.1.3 Global Diabetes Lancing Devices Sales Market Share by Type (2018-2029)
4.2 Global Diabetes Lancing Devices Revenue by Type (2018-2029)
4.2.1 Global Diabetes Lancing Devices Revenue by Type (2018-2023)
4.2.2 Global Diabetes Lancing Devices Revenue by Type (2024-2029)
4.2.3 Global Diabetes Lancing Devices Revenue Market Share by Type (2018-2029)
4.3 Global Diabetes Lancing Devices Price by Type (2018-2029)
5 Segment by Application
5.1 Global Diabetes Lancing Devices Sales by Application (2018-2029)
5.1.1 Global Diabetes Lancing Devices Sales by Application (2018-2023)
5.1.2 Global Diabetes Lancing Devices Sales by Application (2024-2029)
5.1.3 Global Diabetes Lancing Devices Sales Market Share by Application (2018-2029)
5.2 Global Diabetes Lancing Devices Revenue by Application (2018-2029)
5.2.1 Global Diabetes Lancing Devices Revenue by Application (2018-2023)
5.2.2 Global Diabetes Lancing Devices Revenue by Application (2024-2029)
5.2.3 Global Diabetes Lancing Devices Revenue Market Share by Application (2018-2029)
5.3 Global Diabetes Lancing Devices Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Roche
6.1.1 Roche Corporation Information
6.1.2 Roche Description and Business Overview
6.1.3 Roche Diabetes Lancing Devices Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Roche Diabetes Lancing Devices Product Portfolio
6.1.5 Roche Recent Developments/Updates
6.2 LifeScan
6.2.1 LifeScan Corporation Information
6.2.2 LifeScan Description and Business Overview
6.2.3 LifeScan Diabetes Lancing Devices Sales, Revenue and Gross Margin (2018-2023)
6.2.4 LifeScan Diabetes Lancing Devices Product Portfolio
6.2.5 LifeScan Recent Developments/Updates
6.3 Abbott
6.3.1 Abbott Corporation Information
6.3.2 Abbott Description and Business Overview
6.3.3 Abbott Diabetes Lancing Devices Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Abbott Diabetes Lancing Devices Product Portfolio
6.3.5 Abbott Recent Developments/Updates
6.4 Ascensia
6.4.1 Ascensia Corporation Information
6.4.2 Ascensia Description and Business Overview
6.4.3 Ascensia Diabetes Lancing Devices Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Ascensia Diabetes Lancing Devices Product Portfolio
6.4.5 Ascensia Recent Developments/Updates
6.5 B. Braun
6.5.1 B. Braun Corporation Information
6.5.2 B. Braun Description and Business Overview
6.5.3 B. Braun Diabetes Lancing Devices Sales, Revenue and Gross Margin (2018-2023)
6.5.4 B. Braun Diabetes Lancing Devices Product Portfolio
6.5.5 B. Braun Recent Developments/Updates
6.6 Terumo
6.6.1 Terumo Corporation Information
6.6.2 Terumo Description and Business Overview
6.6.3 Terumo Diabetes Lancing Devices Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Terumo Diabetes Lancing Devices Product Portfolio
6.6.5 Terumo Recent Developments/Updates
6.7 ARKRAY
6.6.1 ARKRAY Corporation Information
6.6.2 ARKRAY Description and Business Overview
6.6.3 ARKRAY Diabetes Lancing Devices Sales, Revenue and Gross Margin (2018-2023)
6.4.4 ARKRAY Diabetes Lancing Devices Product Portfolio
6.7.5 ARKRAY Recent Developments/Updates
6.8 Trividia Health
6.8.1 Trividia Health Corporation Information
6.8.2 Trividia Health Description and Business Overview
6.8.3 Trividia Health Diabetes Lancing Devices Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Trividia Health Diabetes Lancing Devices Product Portfolio
6.8.5 Trividia Health Recent Developments/Updates
6.9 SANNUO
6.9.1 SANNUO Corporation Information
6.9.2 SANNUO Description and Business Overview
6.9.3 SANNUO Diabetes Lancing Devices Sales, Revenue and Gross Margin (2018-2023)
6.9.4 SANNUO Diabetes Lancing Devices Product Portfolio
6.9.5 SANNUO Recent Developments/Updates
6.10 GMMC
6.10.1 GMMC Corporation Information
6.10.2 GMMC Description and Business Overview
6.10.3 GMMC Diabetes Lancing Devices Sales, Revenue and Gross Margin (2018-2023)
6.10.4 GMMC Diabetes Lancing Devices Product Portfolio
6.10.5 GMMC Recent Developments/Updates
6.11 BIONIME
6.11.1 BIONIME Corporation Information
6.11.2 BIONIME Diabetes Lancing Devices Description and Business Overview
6.11.3 BIONIME Diabetes Lancing Devices Sales, Revenue and Gross Margin (2018-2023)
6.11.4 BIONIME Diabetes Lancing Devices Product Portfolio
6.11.5 BIONIME Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Diabetes Lancing Devices Industry Chain Analysis
7.2 Diabetes Lancing Devices Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Diabetes Lancing Devices Production Mode & Process
7.4 Diabetes Lancing Devices Sales and Marketing
7.4.1 Diabetes Lancing Devices Sales Channels
7.4.2 Diabetes Lancing Devices Distributors
7.5 Diabetes Lancing Devices Customers
8 Diabetes Lancing Devices Market Dynamics
8.1 Diabetes Lancing Devices Industry Trends
8.2 Diabetes Lancing Devices Market Drivers
8.3 Diabetes Lancing Devices Market Challenges
8.4 Diabetes Lancing Devices Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Companies Mentioned:

Roche
LifeScan
Abbott
Ascensia
B. Braun
Terumo
ARKRAY
Trividia Health
SANNUO
GMMC
BIONIME

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂